Veterinary Biomarkers Market Poised to Unlock New Business Avenues Between 2026–2030
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Aptamers Market Over The Period 2026–2030?
The veterinary biomarkers market has seen rapid expansion in recent years. Its value is forecast to rise from $0.91 billion in 2025 to $1.02 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.4%. Throughout the historic period, this growth was primarily fueled by factors such as a reliance on conventional diagnostic methods, the restricted availability of biomarkers, an increasing occurrence of animal diseases, traditional veterinary research techniques, and the limited adoption of preclinical research tools.
The veterinary biomarkers market size is anticipated to undergo swift expansion in the forthcoming years. It is projected to reach $1.61 billion in 2030, achieving a compound annual growth rate (CAGR) of 12.0%. This growth over the forecast period is primarily fueled by advancements in biomarker discovery, increased investment in veterinary diagnostics, rising awareness surrounding animal health monitoring, the expansion of companion and production animal segments, and the adoption of automated biomarker readers and digital platforms. Key trends expected during this period include the broadening of diagnostic biomarker development, an increase in predictive and prognostic biomarker applications, greater adoption of ELISA, PCR, and rapid test kits, the growing use of advanced biomarker readers and analytical devices, and an enhanced focus on the health of both companion and production animals.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20680&type=smp
Which Major Factors Are Driving The Expansion Of The Aptamers Market?
The growing trend of pet ownership is projected to propel the expansion of the veterinary biomarkers market. Pet ownership refers to the state of having one or more animals as companions, where individuals provide care, shelter, and attention to meet their animals’ needs and ensure their well-being. This rise in pet ownership can be attributed to several factors, including the desire for companionship, the therapeutic benefits pets offer, and a growing awareness of their positive impact on mental and physical health. In the context of pet ownership, veterinary biomarkers are employed to monitor animal health, enabling early disease detection and personalized treatment plans. For instance, according to the Petfood Industry, a US-based organization, in June 2025, 94 million U.S. households owned at least one pet, an increase from 82 million in 2023, highlighting a significant surge in pet ownership and a rising demand for pet care products and services. Therefore, the increasing pet ownership is a key driver for the growth of the veterinary biomarkers market.
How Is The Aptamers Market Divided Into Its Major Segments?
The veterinary biomarkers market covered in this report is segmented –
1) By Product Type: Biomarkers, Kits And Reagents, Biomarker Readers
2) By Disease Type: Inflammatory And Infectious Diseases, Cardiovascular Diseases, Skeletal Muscle Diseases, Tumor, Other Disease Types
3) By Animal Type: Companion Animals, Production Animals
4) By Application: Disease Diagnostics, Preclinical Research, Other Applications
Subsegments:
1) By Biomarkers: Diagnostic Biomarkers, Prognostic Biomarkers, Predictive Biomarkers, Pharmacodynamic Biomarkers
2) By Kits And Reagents: ELISA Kits, PCR Kits, Western Blotting Kits, Rapid Test Kits, Reagents For Biomarker Detection
3) By Biomarker Readers: Optical Readers, Fluorescence Readers, Luminometers, Real-Time PCR Machines, Microplate Readers
How Are Trends Transforming The Veterinary Biomarkers Market Landscape?
Leading companies operating in the veterinary biomarkers market are primarily focused on forging strategic partnerships to gain a competitive edge. These strategic collaborations in the veterinary biomarkers field involve alliances between companies, research institutions, and veterinary practices, aimed at advancing the development and application of diagnostic tools. For example, in November 2025, Bionote USA, a US-based veterinary diagnostics company, unveiled the Vcheck C1 In-Clinic Chemistry Analyzer. This affordable, compact biochemistry testing device is designed to expand point-of-care biomarker and diagnostic capabilities for veterinary practices. The Vcheck C1 enables the concurrent analysis of up to 24 biochemical parameters from small animal samples in 10–12 minutes, delivering laboratory-grade accuracy with a straightforward workflow. It supports testing across 34 species, including canine, feline, equine, and bovine patients, providing validated reference ranges for each species. Featuring comprehensive test panels such as overall chemistry, electrolyte, liver, kidney, and diabetes profiles, the analyzer assists clinicians in quickly diagnosing and monitoring health conditions without the need to send samples to external laboratories. The product’s cost-effective pricing and multi-species compatibility are intended to enhance access to rapid, in-clinic biomarker diagnostics across a wide array of veterinary settings.
Who Are The Prominent Organizations Shaping The Aptamers Market?
Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Zoetis Inc., IDEXX Laboratories Inc., Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB., MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited, VolitionRx, BioVet Diagnostics, Randox Laboratories Ltd., Bio-Rad Laboratories Inc., QIAGEN N.V., FidoCure, Scil Animal Care Company GmbH, Shenzhen Mindray Animal Medical Technology Co. Ltd., Esaote SPA, Innovative Diagnostics SAS, Ayoxxa Biosystems
Read the full veterinary biomarkers market report here:
https://www.thebusinessresearchcompany.com/report/veterinary-biomarkers-global-market-report
Which Region Currently Holds The Largest Share Of The Aptamers Market?
North America was the largest region in the veterinary biomarkers market in 2025. The regions covered in the veterinary biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Aptamers Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=20680&type=smp
Browse Through More Reports Similar to the Global Veterinary Biomarkers Market 2026, By The Business Research Company
Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2026
Veterinary Dermatology Drugs Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report
Veterinary Dietary Supplements Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model